Monitoring Atrial Fibrillation After ICU Treatment
Tracking Atrial Fibrillation After Intensive Care Admission
This study is testing if a special chest patch can help monitor patients for new atrial fibrillation after they leave the ICU to see how often it comes back.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 16 Years and up |
| Sex | All |
| Sponsor | University of Oxford Academic / other |
| Locations | 1 site (Oxford, Oxfordshire) |
| Trial ID | NCT05229211 on ClinicalTrials.gov |
What this trial studies
This study aims to assess the feasibility of screening patients for new onset atrial fibrillation (AF) after their admission to an intensive care unit (ICU). Patients without a prior history of AF who develop this condition during their ICU stay will be continuously monitored for 14 days post-discharge using a chest patch for cardiac rhythm monitoring. Follow-up assessments will occur at three months post-discharge to evaluate the recurrence of AF. Data on medical history and post-hospitalization complications will also be collected to understand the long-term outcomes of these patients.
Who should consider this trial
Good fit: Ideal candidates are adults aged 16 years or older who have been admitted to the ICU for more than 24 hours and have developed new onset atrial fibrillation.
Not a fit: Patients with a prior history of atrial fibrillation or those unable to undergo cardiac monitoring will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the management and monitoring of patients at risk for atrial fibrillation after critical illness.
How similar studies have performed: While studies on atrial fibrillation monitoring exist, this specific approach of post-ICU monitoring for new onset AF is novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Willing and able to give informed consent for participation in the study, or favourable consultee advice for adults lacking capacity * Male or Female, * aged 16 years or above. * Admitted to intensive care for \>24 hours * New onset atrial fibrillation as confirmed by 12 lead ECG- Exclusion Criteria: * History of atrial fibrillation * Unable to undergo cardiac monitoring * Previously included in the study * Not anticipated by treating consultant to survive to ICU discharge (withdrawal or limitation of medical treatment at time of screening) * Contraindication to anticoagulation * Unable to wear the device for the prescribed monitoring period * Implanted neurostimulator, as this may disrupt the ECG recording
Where this trial is running
Oxford, Oxfordshire
- Oxford University Hospitals Trust — Oxford, Oxfordshire, United Kingdom (Recruiting)
Study contacts
- Study coordinator: Peter Watkinson, MD.
- Email: ccrg.research@ndcn.ox.ac.uk@ndcn.ox.ac.uk
- Phone: 01865231448
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.